Loading
RB
Regen Biologics Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by MCNEIL ROBERT G, was filed 20 Apr 2009.
Regen Biologics Inc: what insiders have been doing
Every trade that managers of Regen Biologics Inc disclose to SEC (Form 4) is tracked on this page. No insider at Regen Biologics Inc has published a filing in the past twelve months. The most recent one dates from 20 April 2009.
Since 2006, the database holds 27 purchases and no sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
43
Thresholds
n/a
Buy Volume
€4M
27 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 20 April 2009
Declarations43 total
5,000 shares@ US$2.97COMMON STOCKSEC:0001140361-09-010002:0
Canonical exit: 12 Jul 2009 (T+90)
5,000 shares@ US$2.95COMMON STOCKSEC:0001140361-09-010002:1
Canonical exit: 13 Jul 2009 (T+90)
300 shares@ US$2.50COMMON STOCKSEC:0001140361-09-009074:0
Canonical exit: 30 Jun 2009 (T+90)
5,000 shares@ US$2.90COMMON STOCKSEC:0001140361-09-009074:1
Canonical exit: 1 Jul 2009 (T+90)
5,000 shares@ US$2.92COMMON STOCKSEC:0001140361-09-009074:2
Canonical exit: 2 Jul 2009 (T+90)
1,000 shares@ US$2.50Common StockSEC:0001140361-09-004822:0
Canonical exit: 20 May 2009 (T+90)
1,000 shares@ US$2.60Common StockSEC:0001140361-09-004822:1
Canonical exit: 20 May 2009 (T+90)
62,500 shares@ US$1.80Common StockSEC:0001140361-09-004824:0
1,429 shares@ US$3.50Common StockSEC:0001140361-09-004369:0
Canonical exit: 14 May 2009 (T+90)
2,854 shares@ US$3.50Common StockSEC:0001140361-09-004370:0
Canonical exit: 14 May 2009 (T+90)
17,143 shares@ US$3.50Common StockSEC:0001140361-09-001640:0
Canonical exit: 16 Apr 2009 (T+90)
20,689 shares@ US$3.00Common StockSEC:0001140361-09-001640:1
2,814 shares@ US$3.50Common StockSEC:0001140361-09-001639:0
Canonical exit: 16 Apr 2009 (T+90)
1,035 shares@ US$3.00Common StockSEC:0001140361-09-001639:1
3,376 shares@ US$3.50Common StockSEC:0001140361-09-001636:0
Canonical exit: 16 Apr 2009 (T+90)
1,242 shares@ US$3.00Common StockSEC:0001140361-09-001636:1
7,143 shares@ US$3.50Common StockSEC:0001140361-09-001637:0
Canonical exit: 16 Apr 2009 (T+90)
10,345 shares@ US$3.00Common StockSEC:0001140361-09-001637:1
20,621 shares@ US$3.00Common StockSEC:0001140361-09-001638:1
285,715 shares@ US$3.50Common StockSEC:0001104659-09-003345:0
Canonical exit: 16 Apr 2009 (T+90)
206,882 shares@ US$3.00Common StockSEC:0001104659-09-003345:1
1,142,857 shares@ US$3.50Common StockSEC:0001140361-09-001641:0
Canonical exit: 16 Apr 2009 (T+90)
413,766 shares@ US$3.00Common StockSEC:0001140361-09-001641:1
238,095 sharesCommon StockSEC:0001104659-08-075390:0
238,095 sharesCommon StockSEC:0001104659-08-075389:0
25 of 43 declarations
About Regen Biologics Inc
Regen Biologics Inc is a company listed on the XNAS market, specializing in the development of innovative biological solutions. It focuses on research and commercialization of products to enhance human health.
